Global External beam Radiation Therapy Market Size By Type (Conformal Radiation Therapy, Proton Beam Therapy), By Application (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 to...

The Global External Beam Radiation Therapy (EBRT) Market was valued at USD 7.9 billion in 2023 and is expected to reach USD 13.6 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2023–2031). The increasing prevalence of cancer globally, coupled with the rising demand for non-invasive and precise cancer treatment modalities, is propelling the demand for EBRT systems. These systems deliver targeted radiation doses to destroy cancer cells while minimizing damage to surrounding healthy tissues. Technological advancements, rising investments in oncology care, and increasing awareness about early cancer diagnosis and treatment are significantly contributing to market growth.

Drivers:

1. Rising Incidence of Cancer:

With cancer being one of the leading causes of mortality worldwide, the demand for effective treatment options like EBRT is increasing. Growing awareness and screening initiatives are also promoting early diagnosis and timely therapy, thus boosting market growth.

2. Technological Advancements in Radiation Therapy:

Modern EBRT systems now feature innovations such as image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and stereotactic body radiotherapy (SBRT). These advancements improve treatment precision, efficacy, and safety, encouraging adoption.

3. Government and Private Sector Investments in Oncology Infrastructure:

Various governments and healthcare organizations are investing heavily in building and upgrading cancer treatment centers equipped with EBRT technology, particularly in emerging markets.

Restraints:

1. High Cost of Equipment and Installation:

EBRT systems involve significant capital expenditure, including infrastructure, equipment, and maintenance, which may hinder adoption in low- and middle-income regions.

2. Shortage of Skilled Radiologists and Technicians:

Operating and maintaining EBRT systems requires specialized training. A global shortage of skilled professionals can restrict usage, especially in rural or underdeveloped healthcare systems.

Opportunity:

1. Expanding Oncology Infrastructure in Emerging Economies:

Countries like India, Brazil, and South Africa are investing in oncology treatment facilities, offering ample growth opportunities for EBRT market players.

2. Integration with AI and Big Data Analytics:

The future of EBRT lies in integrating treatment planning and delivery with AI for better outcomes. Predictive analytics and real-time monitoring enhance precision and reduce side effects.

3. Personalized Medicine and Adaptive Radiotherapy:

There is a rising trend toward tailoring radiation doses based on individual patient anatomy and tumor response, creating new avenues for advanced EBRT systems.

Market by System Type Insights:

Among the system types, Linear Accelerators (LINACs) held the largest market share in 2023. LINACs are widely used for their accuracy, speed, and flexibility in treating different cancer types. On the other hand, the Proton Beam Therapy Systems segment is expected to witness the fastest growth due to its potential for highly targeted treatments with fewer side effects, especially in pediatric oncology.

Market by End-use Insights:

Hospitals and Cancer Treatment Centers dominated the market by end-use in 2023. These facilities are typically well-equipped with the required infrastructure and skilled personnel to operate EBRT systems. Meanwhile, Research Institutions and Academic Centers are witnessing increasing adoption as they contribute to clinical research and technological development in radiation oncology.

Market by Regional Insights:

North America led the market in 2023, driven by a high prevalence of cancer, strong reimbursement frameworks, and a well-established healthcare infrastructure. However, Asia-Pacific is projected to register the highest CAGR during the forecast period. Increasing healthcare expenditure, rapid urbanization, and government focus on cancer care are fueling demand in countries like China, India, and Japan.

Competitive Scenario:

Key players in the Global EBRT Market include Varian Medical Systems (a Siemens Healthineers Company), Elekta AB, Accuray Incorporated, Hitachi Ltd., ViewRay Inc., IBA Worldwide, Mevion Medical Systems, and Provision Healthcare. These companies focus on strategic partnerships, technological innovation, and expanding their global footprint.

Scope of Work – Global External Beam Radiation Therapy Market

Report Metric Details

Market Size (2023) USD 7.9 billion

Projected Market Size (2031) USD 13.6 billion

CAGR (2023–2031) 7.2%

Market Segments By System Type (LINAC, Proton Therapy), End-use

Growth Drivers Rising cancer incidence, technological innovation

Opportunities Expansion in emerging markets, AI-integrated therapy

Key Market Developments:

2023: Varian launched an AI-enabled adaptive radiotherapy platform aimed at improving real-time tumor tracking and personalized dose modulation.

2024: Elekta partnered with academic research centers in Europe to advance precision radiotherapy using MR-LINAC systems.

2025: Accuray announced a strategic collaboration with Asian hospitals to expand the availability of CyberKnife robotic radiosurgery systems.

FAQs:

1) What is the current market size of the Global External Beam Radiation Therapy Market?

The market was valued at USD 7.9 billion in 2023.

2) What is the major growth driver of the Global External Beam Radiation Therapy Market?

The primary driver is the rising global incidence of cancer and demand for advanced non-invasive treatments.

3) Which is the largest region during the forecast period in the Global External Beam Radiation Therapy Market?

North America holds the largest market share due to its developed healthcare infrastructure and high adoption of advanced technologies.

4) Which segment accounted for the largest market share in the Global External Beam Radiation Therapy Market?

The Linear Accelerators (LINACs) segment accounted for the largest share in 2023.

5) Who are the key market players in the Global External Beam Radiation Therapy Market?

Key players include Varian Medical Systems, Elekta AB, Accuray, Hitachi Ltd., and ViewRay Inc.